Subsequently, the role of these driver genes in DCIS progression was validated through ADM2 knockdown and RAMP2 overexpression, which, as expected, inhibited the proliferation and migration of breast cancer cell lines. This evidence concerns the gene ADM2 and ductal breast carcinoma in situ.